245.04
+1.95(+0.80%)
Currency In USD
| Previous Close | 243.09 |
| Open | 243.86 |
| Day High | 245.41 |
| Day Low | 242.53 |
| 52-Week High | 263.05 |
| 52-Week Low | 179.42 |
| Volume | 536,317 |
| Average Volume | 1.07M |
| Market Cap | 35.93B |
| PE | 27.5 |
| EPS | 8.91 |
| Moving Average 50 Days | 224.22 |
| Moving Average 200 Days | 233.76 |
| Change | 1.95 |
If you invested $1000 in ResMed Inc. (RMD) 10 years ago, it would be worth $4,230.66 as of May 10, 2025 at a share price of $245.04. Whereas If you bought $1000 worth of ResMed Inc. (RMD) shares 5 years ago, it would be worth $1,506.73 as of May 10, 2025 at a share price of $245.04.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Resmed Acquires VirtuOx
GlobeNewswire Inc.
May 01, 2025 1:00 PM GMT
Acquisition supports Resmed’s growth in virtual care, expands access to diagnosis, and enhances the digital experience for patients and providersSAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology
Resmed Names Salli Schwartz as Chief Investor Relations Officer
GlobeNewswire Inc.
Apr 21, 2025 9:00 PM GMT
Former Illumina, MSCI, and Moody’s executive brings extensive experience leading engagement with the global investment communitySAN DIEGO, April 21, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the global leader in health technology focus
Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US
GlobeNewswire Inc.
Apr 03, 2025 1:00 PM GMT
FDA-cleared home sleep test provides an effective and simplified solution to obstructive sleep apnea testing and diagnosisSAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on s